P301 - Clinical Pharmacists Impact on Diabetes Outcomes in a Primary Care Clinic

Clinical inertia is a barrier to medication optimization in primary care settings. Many factors contribute to clinical inertia, including the workload of primary care providers. One strategy to overcome this is leveraging interdisciplinary teams in primary care to ease this burden. This research poster describes the impact of a pharmacist-led comprehensive medication management service implemented in a primary care rural health clinic. People with type 2 diabetes managed by the clinical pharmacy service from 2021-2023 were compared to those who were not through an electronic medical record review. Outcomes included changes in A1C, as well as rates of prescribing for SGLT2 inhibitors and GLP-1 agonists in patients with comorbidities such as clinical atherosclerotic cardiovascular disease, chronic kidney disease, and heart failure. The poster showcases leveraging an interdisciplinary team in primary care to mitigate clinical inertia in type 2 diabetes care. Author: Jarred Prudencio, PharmD, BCACP, BC-ADM; University of Hawaii at Hilo, the Daniel K. Inouye College of Pharmacy. Funding source: None